Metabolic changes of different high-resolution computed tomography phenotypes of COPD after budesonide–formoterol treatment

Abstract

Bronchial wall thickening in COPD may be an indicator for predicting the better response to the treatment with bronchodilator and corticosteroid. The identification of metabolic alterations provides new insights into different HRCT phenotypes and therapeutic assessment of COPD.